Dante Genomics partners with Emirates Post to deliver advanced genomic services in UAE
The partnership aims to enable universal access to genomic-driven wellness and longevity
NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Emirates Post, the official postal operator and leading express provider in the UAE, has partnered with Dante Genomics, a global leader in genomics and precision medicine, to facilitate the availability of advanced genomic services across the UAE in line with the nation’s vision of making healthcare testing accessible to everyone in the country.
The partnership follows the recent launch of Dante Genomics’ office and operations in the UAE. According to the agreement, Emirates Post will collect and drop off testing kits from Dante Labs to customers across the UAE, in addition to designating Emirates Post Customer Happiness Centers as a point of sale and drop off/collection point for the testing kits. Genetic testing provides personalized information about one’s overall wellbeing to empower them to live a healthier lifestyle.
Peter Somers, CEO of Emirates Post, said: “We are delighted that Dante Genomics entrusted us to support the expansion of their advanced genomic services across the UAE. This partnership further highlights the seamless services we provide to customers through our delivery network, which is the largest in the country. With its customer-centric and diverse choice of services, Emirates Post is an ideal delivery partner for companies looking for expansion and sustainable solutions to even the remotest parts of the country. Our exemplary services have enabled us to build trust and meet all the requirements of our customers and partners.”
Andrea Riposati, Group CEO of Dante Genomics, said that universal access to healthcare requires the universal operations that Emirates Posts has built. “Together, we can deliver advanced genomics everywhere. We are honored to partner with Emirates Post on logistics and distribution of advanced genomic services in the UAE. Emirates Post has proven a fantastic partner with a clear vision of how to democratize access to goods, services and technology for all people in the UAE,” he added.
Dante Genomics is a global leader in genome sequencing with the best technology in the healthcare industry to provide personalized preventive healthcare solutions by offering next-generation diagnostic and prevention tools directly to consumers and healthcare professionals. With the use of proprietary software and patented technologies and leveraging cutting edge sequencers such as the Illumina NovaSeq 6000 and the PacBio Sequel IIe, Dante Genomics has delivered the benefits of the genome to individuals and clinics in 97 countries.
About Dante Genomics
Dante Genomics is a global genomic information company building and commercializing a new class of transformative health and longevity applications based on whole genome sequencing and AI. The Company uses its platform to deliver better patient outcomes from diagnostics to therapeutics with assets including one of the largest private genome databases with research consent, proprietary software designed to unleash the power of genomic data at scale and proprietary processes which enable an industrial approach to genomic sequencing.
About Emirates Post Group
Emirates Post Group Company is a Public Joint Stock Company under Emirates Investment Authority (EIA) operating as a commercial entity across the emirates. It manages the planning of its postal operational division and subsidiaries, which consist of Emirates Post - the leading postal and express delivery provider in the region, Wall Street Exchange, Instant Cash, and the Electronic Documents Centre. The Dubai-based Company is the official entity responsible for licensing all postal, courier and logistics services within the UAE.
Contact:
Laura D’Angelo
VP of Investor Relations
ir@dantelabs.com
+39 0862 191 0671
www.dantelabs.com
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Cool Company Ltd. – Formation Completed1.7.2022 18:46:54 CEST | Press release
Golar LNG Limited ("Golar") announces today that it has sold to Cool Company Ltd. (“CoolCo”) the management organization responsible for the technical and commercial management of LNG carriers, and the provision of such services to third parties, as contemplated in the January 2022 Cool Company Ltd. formation update. CoolCo paid the previously agreed purchase price of $5 million in cash for the shares plus $1.5 million in working capital. As part of the transaction, approximately 600 maritime and office-based personnel became CoolCo employees. Today, Richard Tyrrell also assumed his position as CEO of CoolCo, replacing Interim CEO Karl Fredrik Staubo. FORWARD LOOKING STATEMENTS This press release contains forward-looking statements (as defined in Section 21E of the Securities Exchange Act of 1934, as amended) which reflects management’s current expectations, estimates and projections about its operations. All statements, other than statements of historical facts, that address activitie
Cool Company Ltd. - Formation Completed1.7.2022 18:37:43 CEST | Press release
Cool Company Ltd. ("CoolCo" or the "Company") is pleased to announce today that it has acquired from Golar Management (Bermuda) Limited the management organization responsible for the technical and commercial management of its LNG carriers and the provision of such services to third parties, as contemplated in the January 2022 Cool Company Ltd. formation update. CoolCo paid the previously agreed purchase price of $5 million in cash for the shares plus $1.5 million in working capital. As part of the transaction, approximately 600 maritime and office-based personnel become employees of CoolCo. Today, Richard Tyrrell also assumed his position as CEO of CoolCo, replacing interim CEO Karl Fredrik Staubo. Richard Tyrrell commented: “CoolCo is delighted to formally welcome the members of the Golar LNG team that provide first class technical and commercial management services to our owned fleet of eight LNG carriers, in addition to providing such services to 20 third party vessels. The acquisi
U.S. Government Orders Additional Monkeypox Vaccines from Bavarian Nordic1.7.2022 16:00:10 CEST | Press release
Bavarian Nordic to supply an additional 2.5 million doses of JYNNEOS® vaccineDoses will be manufactured using existing bulk vaccine from previous orders from BARDADeliveries starting in the fourth quarter of 2022 with the majority to be delivered in 2023 COPENHAGEN, Denmark, July 1, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the U.S. Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, has ordered an additional 2.5 million doses of liquid-frozen JYNNEOS®, a non-replicating smallpox vaccine and the only FDA-approved vaccine against monkeypox. Deliveries under this contract will start in the fourth quarter of 2022 and continue through early 2023. This order comes a few weeks after an order from BARDA for the delivery of 500,000 doses of the vaccine in 2022 in response to the current monkeypox outbreak. With a previous order from BARD
Den amerikanske regering bestiller yderligere vacciner mod abekopper fra Bavarian Nordic1.7.2022 16:00:10 CEST | pressemeddelelse
Bavarian Nordic skal levere yderligere 2,5 mio. doser JYNNEOS® vaccineRåvaccine, produceret under tidligere kontrakter med BARDA, vil blive anvendt til færdigproduktion af doserneLeverancerne vil starte i fjerde kvartal 2022 og fortsætte ind i 2023, hvor hovedparten af doserne vil blive leveret KØBENHAVN, Danmark, 1. juli 2022 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at Biomedical Advanced Research and Development Authority (BARDA), en del af Office of the Assistant Secretary for Preparedness and Response ved U.S. Department of Health and Human Services, har bestilt yderligere 2,5 mio. doser af den flydende-frosne udgave af JYNNEOS®, en ikke-replikerende koppevaccine, og den eneste FDA-godkendte vaccine mod abekopper. Leverancerne vil starte i fjerde kvartal 2022 og fortsætte ind i begyndelsen af 2023. Denne ordre er afgivet få uger efter en anden ordre fra BARDA på levering af 500.000 doser af vaccinen i 2022 til brug i forbindelse med det aktuelle udbrud af abekopper. Med en
Incap Corporation: INCAP GROUP’S HALF-YEAR FINANCIAL REPORT FOR JANUARY–JUNE 2022 AND WEBCAST 28 JULY 20221.7.2022 14:30:00 CEST | Press release
Incap Corporation Press release 1 July 2022 at 3:30 p.m. EEST The corrected release includes the time of the webcast. Incap Group’s half-year financial report for January–June 2022 will be published on Thursday, 28 July 2022 at approximately 09:00 a.m. Finnish time. At that time, reporting materials in Finnish and English will be available on the company's website at https://incapcorp.com/reports-and-presentations/. Webcast The company will hold a webcast on Thursday, 28 July 2022 at 2:00 p.m. EEST. The result will be presented by Otto Pukk, CEO, and Antti Pynnönen, CFO, Incap Corporation. In addition to the result, Incap's UK operations will be presented at the event, and Jamie Maughan, Director of Operations UK will participate in the event. The live webcast can be followed at https://incap.videosync.fi/2022-07-28-half-year-report. During the webcast, the public can ask questions in the chat room at the address mentioned above. The recording of the broadcast will be available on the